Embecta Corp. (EMBC)
5.925
+0.02
(+0.42%)
USD |
NASDAQ |
Sep 28, 15:52
Embecta Cash from Operations (Annual) : 191.70M for Sept. 30, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| September 30, 2025 | 191.70M |
| September 30, 2024 | 35.70M |
| September 30, 2023 | 67.70M |
| September 30, 2022 | 412.20M |
| Date | Value |
|---|---|
| September 30, 2021 | 456.00M |
| September 30, 2020 | 499.00M |
| September 30, 2019 | 505.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Artivion, Inc. | 39.88M |
| Abbott Laboratories | 9.566B |
| AngioDynamics, Inc. | 3.089M |
| Alphatec Holdings, Inc. | 45.23M |
| AtriCure, Inc. | 57.33M |